09:48 AM EST - Numinus Wellness Inc. : Announced a partnership with the Multidisciplinary Association for Psychedelic Studies, to support psychedelic experiential opportunities for practitioners as part of a clinical study. If the Clinical Trial Application submitted to Health Canada is approved, the MDMA-assisted therapy experiential opportunity would be available only through Numinus. Numinus Wellness Inc.
shares T.NUMI are trading unchanged at $0.22.
